TY  - JOUR
AU  - Funk, Maximilian A
AU  - Theurich, Sebastian
TI  - Targeting BCMA in CIDP: Valuable insights gained through multi-omics immune monitoring.
JO  - Med
VL  - 6
IS  - 9
SN  - 2666-6340
CY  - Amsterdam
PB  - Elsevier
M1  - DKFZ-2025-01909
SP  - 100753
PY  - 2025
AB  - Dong et al. present two patients with refractory chronic inflammatory demyelinating polyneuropathy (CIDP), who received treatment with B-cell-maturation antigen (BCMA)-targeted chimeric antigen receptor (CAR)-T cells.1 Extensive concomitant immune monitoring provides insights into the pathogenesis and mechanisms of relapse in CIDP that may help to determine the role of BCMA-targeted CAR-T cell therapy for this disease in the future.
LB  - PUB:(DE-HGF)16
C6  - pmid:40945500
DO  - DOI:10.1016/j.medj.2025.100753
UR  - https://inrepo02.dkfz.de/record/304586
ER  -